Biocon raises ₹4,150 crore through QIP to acquire Mylan's stake in Biocon Biologics and repay associated debt.
Biocon said that proceeds from the QIP will be primarily utilised to meet the cash consideration payable to Mylan Inc.
Hosted on MSN
QIP fundraising hits record high in 2024, real estate bags largest share with ₹22,320 crore: Anarock
The Indian stock market has witnessed significant volatility in recent months, with steep corrections affecting investor sentiment. The correction phase, which began in late September 2024 after ...
The cautious optimism for 2026 comes after a sharp moderation in QIP activity in calendar year 2025. QIP activity to recover in 2026, driven by major, well-prepared deals. 2025 saw fewer QIPs and ...
Biotech firm Biocon on Thursday said it has raised Rs 4,150 crore through a Qualified Institutions Placement (QIP) process.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback